NeuroBo Pharmaceuticals Price to Free Cash Flow Ratio 1970-1969 | MTVA
Historical price to free cash flow ratio values for NeuroBo Pharmaceuticals (MTVA) since 1970.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| NeuroBo Pharmaceuticals Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
|
0.00 |
|
nan |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
